In mammal, cancer cells express the M2 isoform of PK26, and although PKM2 is less efficient at catabolizing ATP and PEP to pyruvate, its activity is more easily regulated by the energy molecules, upstream glycolytic intermediates, and growth factors. The gene discussed is PKM; the disease is cancer.